Small molecule fluorophore and copolymer RGD peptide conjugates for ex vivo two-photon fluorescence tumor vasculature imaging

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8477-8485

  Morales, Alma R ^a   Yanez, Ciceron O ^a   Zhang, Yuanwei ^a   Wang, Xuhua ^a   Biswas, Sanchita ^a   Urakami, Takeo ^b   Komatsu, Masanobu ^b   Belfield, Kevin D ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Copolymer probe; Fluorescent dyes; RGD peptide conjugates; Tumor vasculature; Two photon absorption; Two photon fluorescence microscopy

Indexed keywords

FLUORESCENT DYES; RGD PEPTIDE; TUMOR VASCULATURE; TWO-PHOTON ABSORPTIONS; TWO-PHOTON FLUORESCENCE MICROSCOPY;

BLOCK COPOLYMERS; BLOOD VESSELS; FLUORESCENCE; FLUOROPHORES; MOLECULES; PEPTIDES; PHOTONS; PROBES; THREE DIMENSIONAL; TWO PHOTON PROCESSES;

TUMORS;

ARGINYLGLYCYLASPARTIC ACID; COPOLYNORBORNENE ARGINYLGLYCYLASPARTIC ACID CONJUGATE; FLUORENE ARGINYLGLYCYLASPARTIC ACID CONJUGATE; FLUORENE DERIVATIVE; FLUORESCENT DYE; NORBORNENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURGERY; CONJUGATE; CONTROLLED STUDY; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; LEWIS CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; FLUORESCENT DYES; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASMS; OLIGOPEPTIDES;

MUS;

EID: 84866153774     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.082     Document Type: Article

References (47)

1. 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A 1996, 93:9764-9769.
2. 3 for angiogenesis. Science 1994, 264:569-571.
3. 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 1996, 55:1143-1149.
4. Mikecz K. Vitaxin applied molecular evolution. Curr Opin Investig Drugs 2000, 1:199-203.
5. Lainer D.T., Brahn E. New antiangiogenic strategies for the treatment of proliferative synovitis. Expert Opin Investig Drugs 2005, 14:1-17.
6. Ruoslahti E. RGD and other recognition sequences for integrins. Ann Rev Cell Dev Biol 1996, 12:697-715.
7. Humphries M.J. The LDV peptide motif: its role in integrin-ligand binding. Top Mol Med 1995, 1:27-35.
8. Hirano Y., Kando Y., Hayashi T., Goto K., Nakajima A. Synthesis and cell attachment activity of bioactive oligopeptides: RGD, RGDS, RGDV and RGDT. J Biomed Mater Res 1991, 25:1523-1534.
9. 3 integrin antagonists. J Med Chem 1999, 42:3033-3040.
10. Koivunen E., Wang B., Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Nat Biotechnol 1995, 13:265-270.
11. Assa-Munt N., Jia X., Laakkonen P., Ruoslahti E. Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry 2001, 40:2373-2378.
12. Dubey P.K., Mishra V., Jain S., Mahor S., Vyas S.P. Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target 2004, 12:257-264.
13. 3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med 1999, 40:1061-1071.
14. Morrison M.S., Ricketts S.A., Barnett J., Cuthbertson A., Tessier J., Wedge S.R. Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy. J Nucl Med 2009, 50:116-122.
15. 18F-FB-PEG3-Glu- RGD-BBN. J Med Chem 2009, 52:425-432.
16. Scottelius M., Wester H.J. Molecular imaging targeting peptide receptors. Methods 2009, 48:161-177.
17. Zaccaro L., Del Gatto A., Pedone C., Saviano M. Peptides for tumour therapy and diagnosis: current status and future directions. Curr Med Chem 2009, 16:780-795.
18. Shah B.S., Clark P.A., Moioli E.K., Stroscio M.A., Mao J.J. Labeling of mesenchymal stem cells by bioconjugated quantum dots. Nano Lett 2007, 7:3071-3079.
19. Cai W., Shin D.W., Chen K., Gheysens O., Cao Q., Wang S.X., et al. Peptide-labeled near - infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006, 6:669-676.
20. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7:626-634.
21. Kim S., Lim Y.T., Soltesz E.G., Lee J., Nakayama A. Near infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 2004, 22:93-97.
22. 3 in brain tumor xenografts. Cancer Res 2004, 64:8009-8014.
23. 3-positive breast cancer. Bioconjug Chem 2007, 18:438-446.
24. Ye Y., Bloch S., Xu B., Achilefu S. Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem 2006, 49:2268-2275.
25. 3 expression in living mice. Bioconjug Chem 2005, 16:1433-1441.
26. Schraa A.J., Kok R.J., Moorlag H.E., Bos E.J., Proost J.H., Meijer D.K., et al. Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution study. Int J Cancer 2002, 102:469-475.
27. 3 binding peptides for tumor targeting. J Control Release 2006, 114:175-183.
28. 3 expression with near-infrared fluorescent RGD dimer with tetra (ethylene glycol) linkers. Mol Imaging 2010, 9:21-29.
29. Chen K., Xie J., Xu H., Behera D., Michalski M.H., Biswal S., et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009, 30:6912-6919.
30. Williams R.M., Zipfel W.R., Webb W.W. Multiphoton microscopy in biological research. Curr Opin Chem Biol 2001, 5:603-608.
31. Svoboda K., Yasuda R. Principles of two photon excitation microscopy and its applications to neuroscience. Neuron 2006, 50:823-839.
32. Denk W., Strickler J.H., Webb W.W. Two-photon laser scanning fluorescence microscopy. Science 1990, 248:73-76.
33. Helmchen F., Denk W. New developments in multiphoton microscopy. Curr Opin Neurobiol 2002, 12:593-601.
34. Cahalan M.D., Parker I., Wei S.H., Miller M.J. Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol 2002, 2:872-880.
35. Zipfel W.R., Williams R.M., Webb W.W. Nonlinear magic: multiphoton microscopy in the bioscience. Nat Biotechnol 2003, 21:1369-1377.
36. Helmchen F., Denk W. Deep tissue two-photon microscopy. Nat Methods 2005, 2:932-940.
37. Oheim M., Beaurepaire E., Chaigneau E., Mertz J., Charpak S. Two-photon microscopy in brain tissue: parameters influencing the imaging depth. J Neurosci Methods 2001, 111:29-37.
38. Oheim M., Beaurepaire E., Chaigneau E., Mertz J., Charpak S. Two-photon microscopy in brain tissue: parameters influencing the imaging depth. J Neurosci Methods 2001, 112:205.
39. Morales A.R., Luchita G., Yanez C.O., Bondar M.V., Przhonska O.V., Belfield K.D. Linear and nonlinear photophysics and bioimaging of an integrin-targeting water-soluble fluorenyl probe. Org Biomol Chem 2010, 8:2600-2608.
40. Biswas S., Wang X., Morales A.R., Ahn H.Y., Belfield K.D. Integrin-targeting block copolymer probes for two-photon fluorescence bioimaging. Biomacromolecules 2011, 12:441-449.
41. Belfield K.D., Bondar M.V., Przhonska O.V., Schafer K.J. Photostability of a series of two photon absorbing fluorene derivatives. J Photochem Photobiol A Chem 2004, 162:489-496.
42. Belfield K.D., Bondar M.V., Przhonska O.V., Schafer K.J. One- and two-photon photostability of 9,9-didecyl-2,7-bis-(N, N-diphenylamino)fluorene. Photochem Photobiol Sci 2004, 3:138-141.
43. Morales A.R., Yanez C.O., Schafer-Hales K.J., Marcus A.I., Belfield K.D. Biomolecule labeling and imaging with a new fluorenyl two-photon fluorescent probe. Bioconjug Chem 2009, 20:1992-2000.
44. Wang X., Nguyen D.M., Yanez C.O., Rodriguez L., Ahn H.Y., Bondar M.V., et al. High fidelity hydrophilic probe for two-photon fluorescence lysosomal imaging. J Am Chem Soc 2010, 132:12237-12239.
45. Andrade C.D., Yanez C.O., Qaddoura M.A., Wang X., Arnett C.L., Coombs S., et al. Two-photon fluorescence lysosomal bioimaging with a micelle-encapsulated fluorescent probe. J Fluoresc 2011, 21:1223-1230.
46. McDonald D.M., Baluk P. Significance of blood vessel leakiness in cancer. Cancer Res 2002, 62:5381-5385.
47. Maeda H. Tumor -selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.